Supernus Pharmaceuticals, Inc. (SUPN)
45.11
-0.74
(-1.61%)
USD |
NASDAQ |
Aug 24, 16:00
45.11
0.00 (0.00%)
After-Hours: 20:00
Supernus Pharmaceuticals Max Drawdown (5Y) : 60.67% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 60.67% |
| June 30, 2026 | 60.67% |
| May 31, 2026 | 60.67% |
| April 30, 2026 | 60.67% |
| March 31, 2026 | 60.67% |
| February 28, 2026 | 60.67% |
| January 31, 2026 | 60.67% |
| December 31, 2025 | 60.67% |
| November 30, 2025 | 64.41% |
| October 31, 2025 | 69.67% |
| September 30, 2025 | 70.43% |
| August 31, 2025 | 70.43% |
| July 31, 2025 | 70.43% |
| June 30, 2025 | 70.43% |
| May 31, 2025 | 70.43% |
| April 30, 2025 | 70.43% |
| March 31, 2025 | 71.45% |
| February 28, 2025 | 75.86% |
| January 31, 2025 | 75.86% |
| December 31, 2024 | 75.86% |
| November 30, 2024 | 75.86% |
| October 31, 2024 | 75.86% |
| September 30, 2024 | 75.86% |
| August 31, 2024 | 75.86% |
| July 31, 2024 | 75.86% |
| Date | Value |
|---|---|
| June 30, 2024 | 75.86% |
| May 31, 2024 | 75.86% |
| April 30, 2024 | 75.86% |
| March 31, 2024 | 75.86% |
| February 29, 2024 | 75.86% |
| January 31, 2024 | 75.86% |
| December 31, 2023 | 75.86% |
| November 30, 2023 | 75.86% |
| October 31, 2023 | 75.86% |
| September 30, 2023 | 75.86% |
| August 31, 2023 | 75.86% |
| July 31, 2023 | 75.86% |
| June 30, 2023 | 75.86% |
| May 31, 2023 | 75.86% |
| April 30, 2023 | 75.86% |
| March 31, 2023 | 75.86% |
| February 28, 2023 | 75.86% |
| January 31, 2023 | 75.86% |
| December 31, 2022 | 75.86% |
| November 30, 2022 | 75.86% |
| October 31, 2022 | 75.86% |
| September 30, 2022 | 75.86% |
| August 31, 2022 | 75.86% |
| July 31, 2022 | 75.86% |
| June 30, 2022 | 75.86% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Indivior Pharmaceuticals, Inc. | 96.00% |
| Pfizer Inc. | 58.95% |
| Amphastar Pharmaceuticals, Inc. | 74.05% |
| Collegium Pharmaceutical, Inc. | 51.32% |
| Bristol Myers Squibb Co. | 47.67% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 2.288 |
| Beta (5Y) | 0.5636 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 32.78% |
| Historical Sharpe Ratio (5Y) | 0.228 |
| Historical Sortino (5Y) | 0.4261 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 13.17% |